Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Trimethoprim
Drug ID BADD_D02290
Description Trimethoprim is an antifolate antibacterial agent that inhibits bacterial dihydrofolate reductase (DHFR), a critical enzyme that catalyzes the formation of tetrahydrofolic acid (THF) - in doing so, it prevents the synthesis of bacterial DNA and ultimately continued bacterial survival.[L11893] Trimethoprim is often used in combination with [sulfamethoxazole] due to their complementary and synergistic mechanisms but may be used as a monotherapy in the treatment and/or prophylaxis of urinary tract infections.[L11893,L11830] It is structurally and chemically related to [pyrimethamine], another antifolate antimicrobial used in the treatment of plasmodial infections.[T707]
Indications and Usage As a monotherapy, trimethoprim is indicated for the treatment of acute episodes of uncomplicated urinary tract infections caused by susceptible bacteria, including _E. coli._, _K. pneumoniae_, _Enterobacter spp._, _P. mirabilis_, and coagulase-negative _Staphylococcus_ species.[L11893,L11890] In various formulations in combination with [sulfamethoxazole], trimethoprim is indicated for the following infections caused by bacteria with documented susceptibility: urinary tract infections, acute otitis media in pediatric patients (when clinically indicated), acute exacerbations of chronic bronchitis in adults, enteritis caused by susceptible _Shigella_, prophylaxis and treatment of _Pneumocystis jiroveci_ pneumonia, and travelers' diarrhea caused by enterotoxigenic _E. coli_.[L11830,L11863] Trimethoprim is available as an ophthalmic solution in combination with [polymyxin B] for the treatment of acute bacterial conjunctivitis, blepharitis, and blepharoconjunctivitis caused by susceptible bacteria.[L11887]
Marketing Status approved; vet_approved
ATC Code J01EA01
DrugBank ID DB00440
KEGG ID D00145
MeSH ID D014295
PubChem ID 5578
TTD Drug ID D0AO5H
NDC Product Code 64374-001; 43386-330; 38779-0770; 65863-0008; 49452-7925; 40032-330; 60592-716; 62991-3173; 70954-541; 51927-1693; 51862-486; 57451-1111; 57451-1202; 65863-0004; 62991-2072; 72672-001; 51407-738
UNII AN164J8Y0X
Synonyms Trimethoprim | Trimpex | Proloprim
Chemical Information
Molecular Formula C14H18N4O3
CAS Registry Number 738-70-5
SMILES COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Hepatic necrosis09.01.07.002--
Hepatitis09.01.07.0040.001312%-
Hyperkalaemia14.05.03.0010.001837%
Hypersensitivity10.01.03.0030.006665%
Hypersensitivity vasculitis01.01.04.008; 10.02.02.017; 23.06.02.005; 24.12.04.013---
Hypoglycaemia05.06.03.001; 14.06.03.001--
Hyponatraemia14.05.04.0020.002362%
Hypotension24.06.03.0020.001312%
Hypovolaemia14.05.05.0020.000525%-
Immune system disorder10.02.01.001---
Insomnia17.15.03.002; 19.02.01.002--
Iridocyclitis06.04.03.0010.000525%-
Jaundice01.06.04.004; 09.01.01.004; 23.03.03.0300.002099%-
Jaundice cholestatic09.01.01.005---
Lethargy08.01.01.008; 17.02.04.003; 19.04.04.0040.000525%
Leukopenia01.02.02.001---
Lip swelling07.05.04.005; 10.01.05.005; 23.04.01.0070.002886%-
Loss of consciousness17.02.04.004---
Malaise08.01.01.0030.003779%
Meningitis aseptic11.01.03.002; 17.06.03.002---
Methaemoglobinaemia01.05.01.002--
Muscle rigidity15.05.04.001; 17.05.02.0050.000525%-
Myalgia15.05.02.001--
Nausea07.01.07.0010.004408%
Nervous system disorder17.02.10.001---
Neuritis17.09.03.001---
Neuropathy peripheral17.09.03.003---
Neutropenia01.02.03.0040.000787%-
Nightmare19.02.03.003---
Ocular hyperaemia06.04.05.0040.001155%-
The 3th Page    First    Pre   3 4 5 6    Next   Last    Total 6 Pages